Zobrazeno 1 - 10
of 894
pro vyhledávání: '"Novel oral anticoagulants"'
Autor:
Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi
Publikováno v:
Italian Journal of Medicine, Vol 18, Iss 4 (2024)
To date, no retrospective or real-world studies have comprehensively examined the interactions between direct-acting antivirals (DAAs) and widely used medications such as novel oral anticoagulant, statins, and antihypertensive agents. However, clinic
Externí odkaz:
https://doaj.org/article/79ef50596dd640da94e5784e129c6c60
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 17, Pp 945-953 (2024)
Shuo Tian,1,2,* Haitao Zhong,3,4,* Mengyue Yin,5 Pei Jiang,3 Qiao Liu1 1Department of Pharmacy, The Second Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, People’s Republic of China; 2Department of C
Externí odkaz:
https://doaj.org/article/c29a4aac965c4df38627369343950ef0
Autor:
Marius Rus, Adriana Ioana Ardelean, Simina Crisan, Paula Marian, Oana Lilliana Pobirci, Veronica Huplea, Claudia Judea Pusta, Gheorghe Adrian Osiceanu, Claudia Elena Stanis, Felicia Liana Andronie-Cioara
Publikováno v:
Clinics and Practice, Vol 14, Iss 1, Pp 344-360 (2024)
Background and objectives: Atrial fibrillation (AF) is a common arrhythmia associated with various risk factors and significant morbidity and mortality. Materials and methods: This article presents findings from a study involving 345 patients with pe
Externí odkaz:
https://doaj.org/article/01efc86c26954f5f8bf57cd850fd02d4
Autor:
Sumudu A. Hewage, Rini Noviyani, David Brain, Pakhi Sharma, William Parsonage, Steven M. McPhail, Adrian Barnett, Sanjeewa Kularatna
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background The increasing global prevalence of atrial fibrillation (AF) has led to a growing demand for stroke prevention strategies, resulting in higher healthcare costs. High-quality economic evaluations of stroke prevention strategies can
Externí odkaz:
https://doaj.org/article/1facea0577094b42b0ff393e8cd79f9e
Publikováno v:
Український журнал серцево-судинної хірургії, Vol 31, Iss 3, Pp 111-126 (2023)
Non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) are important pharmaceuticals for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients. Vitamin K antagonist warfarin usage is limited
Externí odkaz:
https://doaj.org/article/b6d0fae2053744ff8d2592b42e99bfe1
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-8 (2023)
Abstract Background This study compares the symptomatic 90-day venous thromboembolism (VTE) rates in patients receiving aspirin to patients receiving low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs), after total hip (THA) and
Externí odkaz:
https://doaj.org/article/603a2d0a27684e1d93dc26555c673f14
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Novel oral anticoagulants (NOACs) have been recommended by guidelines as the first-line drugs for preventing cardiogenic stroke. We aimed to provide an overview of the prescription trends and dosing appropriateness of NOACs in China.Metho
Externí odkaz:
https://doaj.org/article/29751f9e2c804a9e8e62e49288d50139
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 2, Pp 163-169 (2023)
Surgical treatment is often accompanied by such complication as bleeding, and ophthalmic surgery is not an exception. The bleeding risk depends on many factors, the most significant are age, arterial hypertension, hepatic and renal impairment, prior
Externí odkaz:
https://doaj.org/article/d9607d14fbba49aab84064983b6acc95
Publikováno v:
The Egyptian Heart Journal, Vol 75, Iss 1, Pp 1-5 (2023)
Abstract Background Adults with congenital heart disease (ACHD) are a group with an increased risk of thromboembolic complications and arrhythmias. Vitamin K antagonists are the most commonly used thromboprophylaxis therapy in this population. Studie
Externí odkaz:
https://doaj.org/article/ff11be47ad7749d9a11b100146745a29
Publikováno v:
Український журнал серцево-судинної хірургії, Vol 30, Iss 4, Pp 115-121 (2022)
An important point in the provision of highly specialized cardiac surgical care for combat trauma is determination of the optimal time, method and volume of surgical intervention, taking into account the persisting threat of infection with the SARS-C
Externí odkaz:
https://doaj.org/article/17e7e824bdd54e4d8eae07620cd40c92